Removal of xenotropic murine leukemia virus by nanocellulose based filter paper

Biologicals

Volumn 43, Issue 6, 2015, Pages 452-456

  Asper, M ^a   Hanrieder, T ^a   Quellmalz, A ^b   Mihranyan, A ^b  

^a Charles River Biopharmaceutical Services GmbH   (Germany)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cladophora cellulose; Paper making; Recombinant proteins and monoclonal antibodies; Viral contamination; Virus retentive filtration

Indexed keywords

CELLULOSE; GOLD NANOPARTICLE; NANOCELLULOSE; NANOFIBER; UNCLASSIFIED DRUG; GOLD; LATEX; NANOSPHERE; SOLUTION AND SOLUBILITY;

ARTICLE; CONTROLLED STUDY; FILTER; FILTRATION; GAMMARETROVIRUS; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; VALIDATION STUDY; VIRAL CLEARANCE; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS TITRATION; XENOTROPIC MURINE LEUKEMIA VIRUS; ATOMIC FORCE MICROSCOPY; COMPARATIVE STUDY; DRUG CONTAMINATION; ISOLATION AND PURIFICATION; MURINE LEUKEMIA VIRUS; PAPER; POROSITY; PREVENTION AND CONTROL; SCANNING ELECTRON MICROSCOPY; SOLUTION AND SOLUBILITY; ULTRASTRUCTURE; VIRAL TROPISM; VIRUS LOAD;

CELLULOSE; DRUG CONTAMINATION; FILTRATION; GOLD; LATEX; LEUKEMIA VIRUS, MURINE; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, SCANNING; NANOFIBERS; NANOSPHERES; PAPER; PARTICLE SIZE; POROSITY; SOLUTIONS; VIRAL LOAD; VIRAL TROPISM;

EID: 84946488402     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2015.08.001     Document Type: Article

References (51)

1. Bethencourt V. Virus stalls genzyme plant. Nat Biotechnol 2009, 27:681.
2. Merten O.W. Virus contaminations of cell cultures - a biotechnological view. Cytotechnology 2002, 39:91-116.
3. Victoria J.G., Wang C., Jones M.S., Jaing C., McLoughlin K., Gardner S., et al. Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J Virol 2010, 84:6033-6040.
4. Nims R.W., Dusing S.K., Hsieh W.T., Lovatt A., Reid G.G., Onlons D., et al. Detection of cache valley virus in biologics manufactured in CHO cells. Biopharm Int 2008, 21:89-96.
5. Kerr A., Nims R. Adventitious viruses detected in biopharmaceutical bulk harvest samples over a 10 year period. PDA J Pharm Sci Technol 2010, 64:481-485.
6. Nims R.W. Detection of adventitious viruses in biologicals - a rare occurrence. Dev Biol (Basel) 2006, 123:153-164.
7. Rabenau H., Ohlinger V., Anderson J., Selb B., Cinatl J., Wolf W., et al. Contamination of genetically engineered CHO-cells by epizootic haemorrhagic disease virus (EHDV). Biologicals 1993, 21:207-214.
8. Rubino M.J. Experiences with HEK293: a human cell line. PDA J Pharm Sci Technol 2010, 64:392-395.
9. Garnick R.L. Experience with viral contamination in cell culture. Dev Biol Stand 1996, 88:49-56.
10. Garnick R.L. Raw materials as a source of contamination in large-scale cell culture. Dev Biol Stand 1998, 93:21-29.
11. Moody M., Alves W., Varghese J., Khan F. Mouse minute virus (MMV) contamination - a case study: detection, root cause determination, and corrective actions. PDA J Pharm Sci Technol 2011, 65:580-588.
12. Qiu Y., Jones N., Busch M., Pan P., Keegan J., Zhou W., et al. Identification and quantitation of vesivirus 2117 particles in bioreactor fluids from infected Chinese hamster ovary cell cultures. Biotechnol Bioeng 2013, 110:1342-1353.
13. ICH.Q5A Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin. International conference for harmonization of technical requirements for registration of pharmaceuticals for human Use. Geneve, Switzeland 1998.
14. Jayapal K.P., Wlaschin K.F., Hu W.S., Yap M.G.S. Recombinant protein therapeutics from CHO cells - 20 years and counting. Chem Eng Prog 2007, 103:40-47.
15. Houdebine L.M. Transgenic animal bioreactors. Transgenic Res 2000, 9:305-320.
16. Thomas B.R., van Deynze A., Bradford K.J. Production of therapeutic proteins in plants 2002, 1-12. 8078, ANR Publication.
17. Burnouf T., Radosevich M. Nanofiltration of plasma-derived biopharmaceutical products. Haemophilia 2003, 9:24-37.
18. Deo Y., Ghebremariam H., Cloyd M. Detection and characterization of murine ecotropic recombinant virus in myeloma and hybridoma cells. Hybridoma 1994, 13:69-76.
19. Lueders K.K. Genomic organization and expression of endogenous retrovirus-like elements in cultured rodent cells. Biologicals 1991, 19:1-7.
20. Bartal A.H., Feit C., Erlandson R., Hirshaut Y. The presence of viral particles in hybridoma clones secreting monoclonal antibodies. New Engl J Med 1982, 306:1423.
21. Anderson K.P., Lie Y.S., Low M.A., Williams S.R., Wurm F.M., Dinowitz M. Defective endogenous retrovirus-like sequences and particles of Chinese hamster ovary cells. Dev Biol Stand 1991, 75:123-132.
22. Anderson K.P., Lie Y.S., Low M.L., Williams S.R., Fennie E.H., Nguyen T.P., et al. Presence and transcription of intracisternal A-particle-related sequences in CHO cells. J Virol 1990, 64:2021-2032.
23. Jenkins N.A., Copeland N.G. Retroviral DNA content of the mouse genome. Birth Defects Orig Artic Ser 1987, 23:109-122.
24. Kuff E.L., Lueders K.K., Orenstein J.M., Wilson S.H. Differential response of type C and intracisternal type A particle markers in cells treated with iododeoxyuridine and dexamethasone. J Virol 1976, 19:709-716.
25. Lubiniecki A.S., Dinowitz M., Nelson E., Wiebe M., May L., Ogez J., et al. Endogenous retroviruses of continuous cell substrates. Dev Biol Stand 1989, 70:187-191.
26. Lieber M.M., Benveniste R.E., Livingston D.M., Todaro G.J. Mammalian cells in culture frequently release type C viruses. Science 1973, 182:56-59.
27. Lie Y.S., Penuel E.M., Low M.A.L., Nguyen T.P., Mangahas J.O., Anderson K.P., et al. Chinese hamster ovary cells contain transcriptionally active full-length type C proviruses. J Virol 1994, 68:7840-7849.
28. Dinowitz M., Lie Y.S., Low M.A., Lazar R., Fautz C., Potts B., et al. Recent studies on retrovirus-like particles in Chinese hamster ovary cells. Dev Biol Stand 1992, 76:201-207.
29. Donahue R.E., Kessler S.W., Bodine D., McDonagh K., Dunbar C., Goodman S., et al. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 1992, 176:1125-1135.
30. Pedersen F.S., Crowther R.L., Hays E.F., Nowinski R.C., Haseltine W.A. Structure of retroviral RNAs produced by cell lines derived from spontaneous lymphomas of AKR mice. J Virol 1982, 41:18-29.
31. Quint W., Quax W., Van Der Putten H., Berns A. Characterization of AKR murine leukemia virus sequences in AKR mouse substrains and structure of integrated recombinant genomes in tumor tissues. J Virol 1981, 39:1-10.
32. van der Putten H., Quint W., van Raaij J., Robanus Maandag E., Verma I.M., Berns A. M-MuLV-induced leukemogenesis: integration and structure of recombinant proviruses in tumors. Cell 1981, 24:729-739.
33. Levy J.A., Lee H.M., Kawahata R.T., Spitler L.E. Purification of monoclonal antibodies from mouse ascites eliminates contaminating infectious mouse type C viruses and nucleic acids. Clin Exp Immunol 1984, 56:114-120.
34. FDA Points to consider in the manufacturing and testing of monoclonal antibody products for human use 1997, Center for Biologics Evaluation and Research, Washington, DC, FDA.
35. Anonymous Virus filtration. PDA J Pharm Sci Techn 2008, 62:1-60.
36. Aranha H. Viral clearance strategies for biopharmaceutical safety: part I: general considerations. Pharm Techn North Am 2001, 25:22-91.
37. Aranha H., Forbes S. Viral clearance strategies for biopharmaceutical safety: part II: a multifaceted approach to process validation. Pharm Techn North Am 2001, 25:26-31.
38. Oshima K.H., Evans-Strickfaden T.T., Highsmith A.K., Ades E.W. The use of a microporous polyvinylidene fluoride (PVDF) membrane filter to separate contaminating viral particles from biologically important proteins. Biologicals 1996, 24:137-145.
39. Metreveli G., Wågberg L., Emmoth E., Belák S., Strømme M., Mihranyan A. A size-exclusion nanocellulose filter paper for virus removal. Adv Healthc Mater 2014, 3:1546-1550.
40. Quellmalz A., Mihranyan A. Citric acid cross-linked nanocellulose-based paper for size-exclusion nanofiltration. ACS Biomater Sci Eng 2015, 1:271-276.
41. Mihranyan A. Cellulose from Cladophorales green algae: from environmental problem to high-tech composite materials. J App Pol Sci 2011, 119:2449-2460.
42. Ferraz N., Carlsson D.O., Hong J., Larsson R., Fellström B., Nyholm L., et al. Haemocompatibility and ion exchange capability of nanocellulose polypyrrole membranes intended for blood purification. J R Soc Interf 2012, 9:1943-1955.
43. Ferraz N., Leschinskaya A., Toomadj F., Fellström B., Strømme M., Mihranyan A. Membrane characterization and solute diffusion in porous composite nanocellulose membranes for hemodialysis. Cellulose 2013, 20:2959-2970.
44. Ferraz N., Strømme M., Fellström B., Pradhan S., Nyholm L., Mihranyan A. In vitro and in vivo toxicity of rinsed and aged nanocellulose-polypyrrole composites. J Biomed Mat Res - Pt A 2012, 100 A:2128-2138.
45. Ferraz N., Mihranyan A. Is there a future for electrochemically assisted hemodialysis? Focus on the application of polypyrrole-nanocellulose composites. Nanomedicine 2014, 9:1095-1110.
46. Barrett E.P., Joyner L.G., Halenda P.P. The determination of pore volume and area distributions in porous substances. I. Computations from nitrogen isotherms. JACS 1951, 73:373-380.
47. Yeager M., Wilson-Kubalek E.M., Weiner S.G., Brown P.O., Rein A. Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms. Proc Natl Acad Sci U. S. A 1998, 95:7299-7304.
48. Okita Y., Fujisawa S., Saito T., Isogai A. TEMPO-oxidized cellulose nanofibrils dispersed in organic solvents. Biomacromolecules 2011, 12:518-522.
49. Klemm D., Kramer F., Moritz S., Lindström T., Ankerfors M., Gray D., et al. Nanocelluloses: a new family of nature-based materials. Angew Chem - Int Ed 2011, 50:5438-5466.
50. Charreau H., Foresti M.L., Vázquez A. Nanocellulose patents trends: a comprehensive review on patents on cellulose nanocrystals, microfibrillated and bacterial cellulose. Rec Pat Nanotechn 2013, 7:56-80.
51. Nyholm L., Nyström G., Mihranyan A., Strømme M. Toward flexible polymer and paper-based energy storage devices. Adv Mater 2011, 23:3751-3769.